CA2704345C - Melange de lipides pour la nutrition de bebes - Google Patents

Melange de lipides pour la nutrition de bebes Download PDF

Info

Publication number
CA2704345C
CA2704345C CA2704345A CA2704345A CA2704345C CA 2704345 C CA2704345 C CA 2704345C CA 2704345 A CA2704345 A CA 2704345A CA 2704345 A CA2704345 A CA 2704345A CA 2704345 C CA2704345 C CA 2704345C
Authority
CA
Canada
Prior art keywords
composition
composition according
fatty acids
pufa
infant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2704345A
Other languages
English (en)
Other versions
CA2704345A1 (fr
Inventor
Fabiana Bar Yosef
Dori Pelled
Ariel Katz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enzymotec Ltd
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40349932&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2704345(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of CA2704345A1 publication Critical patent/CA2704345A1/fr
Application granted granted Critical
Publication of CA2704345C publication Critical patent/CA2704345C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention porte sur une composition comprenant au moins un triglycéride, au moins un phospholipide, et au moins un acide gras poly-insaturé (LC-PUFA), au moins environ 1% du LC-PUFA de la composition étant conjuguée au ou aux phospholipides. L'invention porte également sur ses utilisations.
CA2704345A 2007-11-01 2008-11-02 Melange de lipides pour la nutrition de bebes Expired - Fee Related CA2704345C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99610907P 2007-11-01 2007-11-01
US60/996,109 2007-11-01
PCT/IL2008/001437 WO2009057121A1 (fr) 2007-11-01 2008-11-02 Mélange de lipides pour la nutrition de bébés

Publications (2)

Publication Number Publication Date
CA2704345A1 CA2704345A1 (fr) 2009-05-07
CA2704345C true CA2704345C (fr) 2016-07-26

Family

ID=40349932

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2704345A Expired - Fee Related CA2704345C (fr) 2007-11-01 2008-11-02 Melange de lipides pour la nutrition de bebes

Country Status (11)

Country Link
US (2) US8975299B2 (fr)
EP (1) EP2230942B1 (fr)
KR (2) KR20150126977A (fr)
CN (2) CN103202353A (fr)
AU (1) AU2008320328B2 (fr)
BR (1) BRPI0818723B1 (fr)
CA (1) CA2704345C (fr)
ES (1) ES2660416T3 (fr)
MX (1) MX2010004820A (fr)
RU (2) RU2488283C2 (fr)
WO (1) WO2009057121A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2488283C2 (ru) 2007-11-01 2013-07-27 Энзимотек Лтд. Липидная смесь для детского питания
PT2341784E (pt) 2008-09-02 2013-02-11 Nutricia Nv Composições nutricionais com glóbulos lipídicos revestidos
WO2010068086A1 (fr) 2008-12-11 2010-06-17 N.V. Nutricia Composition nutritionnelle à globules de lipides de grande taille
CA2779551C (fr) * 2009-11-03 2018-05-01 Dsm Ip Assets B.V. Composition contenant des cellules et un acide gras polyinsature comportant au moins 20 atomes de carbone (lc-pufa)
WO2011115476A1 (fr) 2010-03-17 2011-09-22 N.V. Nutricia Nutrition du nourrisson destinée à améliorer la composition en acides gras des membranes cérébrales à un stade ultérieur de sa vie
KR102186932B1 (ko) 2012-02-17 2020-12-07 알크레스타, 인크. 식이 지방산 수요를 공급하기 위한 방법들, 조성물들 및 디바이스들
SE536599C3 (sv) * 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2014165008A1 (fr) * 2013-03-13 2014-10-09 Abbott Laboratories Procédé permettant d'améliorer la biodisponibilité du dha et d'autres nutriments solubles dans les lipides
US20160166527A1 (en) * 2013-08-01 2016-06-16 Loders Croklaan B.V. Glyceride Composition
PT3091973T (pt) 2013-11-01 2018-11-15 Nutricia Nv Composição lipídica para melhorar a composição corporal durante o crescimento de recuperação
US9216199B2 (en) 2013-12-05 2015-12-22 Buriva, LLC Nutritional supplement containing phospholipid-DHA derived from eggs
US9233114B2 (en) 2013-12-05 2016-01-12 Buriva, LLC Dietary supplement containing phospholipid-DHA derived from eggs
US9610302B2 (en) 2013-12-05 2017-04-04 Buriva, LLC. Composition containing phospholipid-DHA and B vitamins
US9549937B2 (en) 2013-12-05 2017-01-24 Burvia, LLC. Composition containing phospholipid-DHA and folate
ES2761555T3 (es) 2013-12-12 2020-05-20 Nestle Sa Composiciones lácteas sintéticas que comprenden ácido eicosatrienoico n-6 y lípidos polares para niños mayores y menores de tres meses para el establecimiento saludable de la función cognitiva
MX384154B (es) * 2014-12-23 2025-03-14 Evonik Operations Gmbh Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados.
US20170367394A1 (en) * 2014-12-23 2017-12-28 Evonik Degussa Gmbh Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids
WO2017009711A1 (fr) * 2015-07-13 2017-01-19 Enzymotec Ltd. Préparations à base de phospholipides pour l'amélioration du sommeil
US10258590B2 (en) 2015-10-14 2019-04-16 Alcresta Therapeutics, Inc. Enteral feeding device and related methods of use
DK3361885T3 (da) 2015-10-15 2019-07-29 Nutricia Nv Modermælkserstatning med særlig lipidarkitektur til fremme af sund vækst
CN105595323A (zh) * 2015-12-02 2016-05-25 北京世纪合辉医药科技股份有限公司 一种磷脂、不饱和脂肪酸复方保健品及其制备方法
MX2018006295A (es) * 2015-12-14 2018-08-16 Nestec Sa Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
EP3516066A1 (fr) * 2016-09-23 2019-07-31 Wake Forest University Micro-organismes modifiés utilisés comme sources durables de production d'acides gras polyinsaturés oméga-3
BR112019011809B1 (pt) 2016-12-09 2023-02-28 N.V. Nutricia Uso de lipídeo na forma de glóbulos lipídicos
CN113226064A (zh) 2018-12-20 2021-08-06 雀巢产品有限公司 人乳强化剂组合物
KR20220047775A (ko) 2019-07-17 2022-04-19 베이커 하트 앤드 다이어비티스 인스티튜트 인간 피험자의 조직에서 에테르 지질 분자의 혼합물을 유지 또는 조절하기 위한 조성물
AU2021263069B2 (en) * 2020-04-27 2026-02-19 Société des Produits Nestlé S.A. Method for producing milk like products
CN116008438B (zh) * 2023-02-07 2023-06-06 北京三元食品股份有限公司 一种用于评价婴幼儿精细动作发育状况的标志物组及应用
CN115825294B (zh) * 2023-02-07 2023-05-26 北京三元食品股份有限公司 一种用于评价婴幼儿沟通能力和发育状况的标志物组及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0784437T3 (da) 1994-10-05 1999-04-19 Milupa Gmbh & Co Kg Phospholipidholdig fedtblanding med LCP-fedtsyrer
DE19644518A1 (de) * 1996-10-25 1998-04-30 Nutricia Nv Wässrige Fettemulsion, diese enthaltende Nahrung und deren Verwendung
JP2001516343A (ja) 1997-02-21 2001-09-25 アボツト・ラボラトリーズ 壊死性全腸炎の発生を減少させるための方法及び組成物
US20040143013A1 (en) * 2000-02-28 2004-07-22 Bristol-Myers Squibb Company Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants
EP1392623A4 (fr) 2001-05-14 2005-05-04 Martek Biosciences Corp Production et utilisation d'une fraction riche en lipide polaire contenant des acides gras hautement insatures omega 3 et/ou omega 6 de microbes, de semences genetiquement modifiees et d'organismes marins
EP1515616A4 (fr) 2002-03-19 2005-12-28 Advanced Bionutrition Corp Aliments a base de microalgues contenant de l'acide arachidonique et leur procede de production et d'utilisation
US20050129738A1 (en) * 2002-06-16 2005-06-16 Lipogen Ltd. Infant formula supplemented with phospholipids
EP1643862A1 (fr) 2003-06-24 2006-04-12 University of Kansas Medical Center Formule pour bebes
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
IL158554A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
IL158552A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Lipids containing omega-3 fatty acids
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
TWI365716B (en) * 2003-12-02 2012-06-11 Suntory Holdings Ltd Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same
EP1634599A1 (fr) * 2004-08-20 2006-03-15 N.V. Nutricia Aliment infantile à activité immunostimulatrice
US20060229366A1 (en) 2005-04-07 2006-10-12 Lifschitz Carlos H Method for preventing or treating respiratory infections in infants
EP1962617A2 (fr) 2005-12-23 2008-09-03 N.V. Nutricia Compositions nutritionnelles destinees a prevenir l'obesite
RU2469545C2 (ru) * 2007-10-09 2012-12-20 Энзимотек Лтд. Липидная композиция для лечения желудочно-кишечных нарушений и активации развития и созревания кишечника
RU2488283C2 (ru) 2007-11-01 2013-07-27 Энзимотек Лтд. Липидная смесь для детского питания

Also Published As

Publication number Publication date
RU2010122055A (ru) 2011-12-10
KR20100094490A (ko) 2010-08-26
US20150148316A1 (en) 2015-05-28
BRPI0818723B1 (pt) 2020-02-27
WO2009057121A1 (fr) 2009-05-07
RU2611808C2 (ru) 2017-03-01
AU2008320328A1 (en) 2009-05-07
RU2488283C2 (ru) 2013-07-27
US8975299B2 (en) 2015-03-10
EP2230942B1 (fr) 2018-01-10
ES2660416T3 (es) 2018-03-22
CN101909467B (zh) 2013-04-24
CN103202353A (zh) 2013-07-17
KR101597372B1 (ko) 2016-02-24
KR20150126977A (ko) 2015-11-13
BRPI0818723A2 (pt) 2017-05-23
RU2013116385A (ru) 2014-10-20
AU2008320328B2 (en) 2014-10-02
CN101909467A (zh) 2010-12-08
EP2230942A1 (fr) 2010-09-29
US20100298273A1 (en) 2010-11-25
CA2704345A1 (fr) 2009-05-07
MX2010004820A (es) 2010-08-10

Similar Documents

Publication Publication Date Title
CA2704345C (fr) Melange de lipides pour la nutrition de bebes
JP5886044B2 (ja) 認知機能の改善のためのグリセロリン脂質
JP5959137B2 (ja) 乳由来リン脂質を含有する乳幼児脳発達促進剤及びそれを含有する食品組成物
JP6104356B2 (ja) 神経再生のための飲食品
CONNOR et al. Importance of Dietary Omega-3 Fatty Acids in Retinal Function

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20131025

MKLA Lapsed

Effective date: 20211102